New patent for Mallinckrodt Hosp drug INOMAX

Annual Drug Patent Expirations for INOMAX Inomax is a drug marketed by Mallinckrodt Hosp and is included in one NDA. It is available from one supplier. There are seventeen patents…

The post New patent for Mallinckrodt Hosp drug INOMAX appeared first on DrugPatentWatch.


Comments are closed.

Do NOT follow this link or you will be banned from the site!
%d bloggers like this: